NCT03353025

Study on Therapy of Non-invasive Prolactinoma

Prospective Randomized Clinical Study on Transsphenoidal or Dopamine Drugs Therapy Treat Non-invasive Prolactinoma

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 394 (estimated)
• Sponsor: First Affiliated Hospital, Sun Yat-Sen University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Detailed description

Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until now. However，this two type therapies were controversial. The study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Conditions

• Prolactinoma

Interventions

Type	Name	Description
PROCEDURE	transsphenoidal surgery treatment	transsphenoidal surgery treatment
DRUG	dopamine agonist treatment	Minimum effective dose of dopamine agonist，bromocriptine，treat prolactinona

Timeline

• Start date: 2016-01-01
• Primary completion: 2025-12-31
• Completion: 2025-12-31
• First posted: 2017-11-24
• Last updated: 2017-11-24

Locations

1 site across 1 country: China